<DOC>
	<DOCNO>NCT03017391</DOCNO>
	<brief_summary>Nausea vomit frequently occur problem palliative phase patient cancer . Between 20-50 % regularly suffer nausea , retch vomit . Often cause nausea vomit multifactorial symptomatic treatment necessary . Potential drug symptomatic anti-nausea therapy metoclopramide , serotonin antagonist , combination dexamethasone rescue medication case failure . There data depicts strategy best . This study conduct unravel treatment algorithm successful .</brief_summary>
	<brief_title>Treatment Algorithm Nausea Vomiting Palliative Phase</brief_title>
	<detailed_description>Nausea vomit frequently occur problem palliative phase patient cancer . Between 20-50 % regularly suffer nausea , retch vomit . Often cause nausea vomit multifactorial symptomatic treatment necessary . Potential drug symptomatic anti-nausea therapy metoclopramide , serotonin antagonist , combination dexamethasone rescue medication case failure . There data depicts strategy best . This study conduct unravel treatment algorithm successful : 1 start metoclopramide , add serotonin antagonist ( granisetron transdermal patch 2 milligram granisetron oral load dose patient swallow ) case failure add dexamethasone rescue medication versus 2 algorithm start serotonin antagonist ( granisetron transdermal patch 2 milligram granisetron oral load dose patient swallow ) , add metoclopramide case failure add dexamethasone rescue medication . Granisetron plaster new formulation well know serotonin antagonist might useful especially within patient group palliative phase . The question : Is feasible compare treatment algorithms symptomatic treatment nausea vomit palliative cancer patient ? And stepwise symptomatic treatment algorithm manage nausea vomit use metoclopramide granisetron transdermal patch start medication effective palliative patient least one treatment arm ? Patients ask complete QLQC30 ESAS different moment study . Besides , ask complete diary nausea severity ( NRS scale 0-10 ) frequency vomit retch twice daily . Success treatment algorithm define nausea &lt; 3 NRS decrease &gt; 2 NRS nausea combine absence vomit retch last 3 day . Incomplete success define nausea 3 NRS one occasion last 3 day end study less 4 , one retching day period absence vomit . Complete failure define nausea 4 NRS last 3 day one retch daily vomit case patient stop medication due side effect .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Metoclopramide</mesh_term>
	<mesh_term>Granisetron</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>patient 18 year older palliative phase suffer nausea vomit rating numeric rating scale ( NRS ) 2 wish treat treatable cause assignable Patients able sign inform consent . Patients known contraindication metoclopramide , 5HT3 antagonist dexamethasone .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>palliative care</keyword>
	<keyword>palliative medicine</keyword>
	<keyword>palliative</keyword>
</DOC>